Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2025
Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024Katherine Adams, Shikha Garg, Sara Y Tartof, et al.The Journal of Infectious Diseases|July 25, 2024
Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023Mark W Tenforde, Zachary A Weber, Duck-Hye Yang, et al.Lancet Regional Health. Americas|June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort studyKatherine Adams, John J Riddles, Elizabeth A K Rowley, et al.MMWR. Morbidity and Mortality Weekly Report|August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.MMWR. Morbidity and Mortality Weekly Report|May 25, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.JAMA Network Open|September 26, 2022
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United StatesStephanie J Schrag, Jennifer R Verani, Brian E Dixon, et al.MMWR. Morbidity and Mortality Weekly Report|December 11, 2025
Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025Stephanie A Irving, Elizabeth A K Rowley, Sean Chickery, et al.JAMA Network Open|June 23, 2026
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative DesignRyan E Wiegand, Sean Chickery, Duck-Hye Yang, et al.The Journal of Infectious Diseases|January 23, 2023
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION NetworkMark W Tenforde, Zachary A Weber, Malini B DeSilva, et al.Pageof 8